ABSTRACT
Background Psoriatic arthritis (PsA) is a chronic inflammatory disease characterised by clinical features that include bone loss and epidermal hyperplasia. Aberrant cytokine expression has been linked to joint and skin pathology; however, it is unclear which cytokines are critical for disease initiation. Interleukin 17A (IL-17A) participates in many pathological immune responses; however, its role in PsA has not been fully elucidated.
Objective To determine the role of IL-17A in epidermal hyperplasia and bone destruction associated with psoriatic arthritis. Design An in vivo gene transfer approach was used to investigate the role of IL-17A in animal models of inflammatory (collagen-induced arthritis) and non-inflammatory (receptor activator of NF-κB ligand (RANKL)-gene transfer) bone loss. Results IL-17A gene transfer induced the expansion of IL-17RA + CD11b + Gr1 low osteoclast precursors and a concomitant elevation of biomarkers indicative of bone resorption. This occurred at a time preceding noticeable joint inflammation, suggesting that IL-17A is critical for the induction of pathological bone resorption through direct activation of osteoclast precursors. Moreover, IL-17A induced a second myeloid population CD11b + Gr1 high neutrophil-like cells, which was associated with cutaneous pathology including epidermal hyperplasia, parakeratosis and Munro's microabscesses formation. Conclusions Collectively, these data support that IL-17A can play a key role in the pathogenesis of inflammation-associated arthritis and/or skin disease, as observed in PsA.
INTRODUCTION
Psoriatic arthritis (PsA) is an inflammatory rheumatic disorder of unknown aetiology occurring concurrently or before the onset of psoriasis. In PsA patients, psoriatic features of epidermal hyperplasia accompanied by parakeratosis (retention of keratinocyte nuclei in the stratum corneum) and neutrophilic exudates in the epidermis (Munro's microabscesses) are sometimes followed many years later by synovial inflammation, bone destruction and juxta-articular new bone formation. 1 Bone destruction is the result of excess differentiation and/or activation of osteoclasts, a cell uniquely specialised to carry out bone resorption. 2 Osteoclast precursors circulate in peripheral blood and differentiate into multinucleated osteoclasts in the presence of macrophage-colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ-B ligand (RANKL). 3 4 Interleukin 17A (IL-17A), together with other T helper 17 cell (T h 17)-related cytokines, has been detected in the synovium and synovial fluid of rheumatoid patients, as well as in human psoriatic skin lesions.
5-7 IL-23, which plays a major role in T h 17-cell development and IL-17A production, stimulates epidermal hyperplasia, enthesitis, synovial inflammation and bone destruction in rheumatic disease models. [8] [9] [10] Although T h 17 cells have been implicated in the pathogenesis of psoriasis and PsA, the contribution of IL-17A versus IL-23 or other T h 17-related cytokines such as IL-22 remains puzzling. [11] [12] [13] [14] [15] Similarly, IL-23 and IL-17A are also associated with changes in the RANKL-RANK axis and increased osteoclast formation that can lead to bone pathology. [16] [17] [18] Although IL-17RA was not critical in experimental psoriasis-like skin inflammation, other reports showed that blockade of IL-17A or IL-17RA led to rapid clinical response in subjects with moderate-to-severe psoriasis. 19 20 More recent evidence using IL-17A-commited γ4 + γδ T cells highlighted a role of IL-17A in the development of psoriasis-like skin changes. 21 Taken together, a plethora of evidence suggests a role of IL-17A in PsA pathology via indirect mechanisms involving γδ T cells, epithelial, endothelial and fibroblastic cells.
In 
Gr1
high neutrophil-like cell subset associated with Munro's microabscesses and epidermal hyperplasia with associated parakeratosis typically observed in psoriasis. Both osteoclast-mediated bone resorption and epidermal hyperplasia are hallmarks of PsA. Collectively our data support IL-17A as a possible target to combat PsA and reveal a novel link between IL-17 and cells of haematopoietic origin that are associated with joint and skin pathology observed in PsA.
METHODS

Mice and reagents
Merck Research Labs and UC Davis Institutional Animal Care and Use Committee approved all animal protocols. C57BL/6J mice (The Jackson Laboratory, Sacramento, California, USA) were sacrificed by carbon dioxide exposure and blood collected by cardiac puncture. All cell incubations were performed in culture medium consisting of α minimal essential medium (αMEM) (Invitrogen, USA), 2 mM glutamine, 10% heat-inactivated fetal bovine serum (Invitrogen), 100 IU/mL penicillin and 100 μg/mL streptomycin. Mouse M-CSF and RANKL, RANKL and IL-17A ELISA were purchased from R&D Systems (USA). Serum CTX-I and tartrate-resistant acid phosphatase 5b (TRAP5b) were measured using a RatLaps-EIA kit from Nordic Bioscience Diagnostics A/S and ELISA from Sigma (St Louis, USA), respectively. APC-conjugated anti-mouse CD115 (AFS98), PE-Cy5-conjugated anti-mouse Gr-1 (RB6-8C5), Pacific blue-conjugated anti-mouse CD11b (M1/70), biotin-conjugated anti-mouse RANK (R12-31), Streptavidin 605 violet, Biotin and PE rat IgG2a isotypes (RTK2758), and PE-conjugated anti-mouse RANK (R12-31) were all purchased from Biolegend.
Production and purification of minicircle DNA
Mouse IL-17A and RANKL minicircle (MC)-DNA constructs were produced according to methods described previously 22 and adjusted to 1 L culture volume. Single isolated colony from a fresh plate was grown for 8 h in 2 mL Luria-Bertani broth with ampicillin. Inoculated 800 μL of this culture onto 1 L of Terrific broth and grown for additional 17 h. Overnight cultures were centrifuged at 20 o C 4000 rpm for 20 min. The pellet was resuspended 4:1 (v/v) in fresh Luria-Bertani broth containing 1% L-arabinose. The bacteria were incubated at 32 o C with constant shaking at 250 rpm for 2 h. After adding one-half volume of fresh low salt Luria-Bertani broth ( pH 8.0) containing 1% L-arabinose, the incubation temperature was increased to 37°C and the incubation continued for an additional 2 h. Episomal DNA circles were prepared from bacteria using the Endofree Qiagen Megaprep plasmid purification kits (Chatsworth, California, USA), and sequences were verified by sequencing on an ABI3130×1 Genetic analyser. 8 μg MC DNA were used for IL-17A and green fluorescent protein (GFP) and 0.5 μg for RANKL in all further experiments. Whole-body and liver explant images 24 h post gene transfer were obtained using a solid-state liquid crystal tunable filter-based imaging technology, Maestro 2 (Cri).
Flow cytometry of isolated bone marrow macrophages and splenocytes
Bone marrow and spleen cells were isolated from C57BL/6J mice 3 days post gene transfer of either GFP or IL-17A MC. Spleens were treated with collagenase (Sigma) for 15 min at 37°C and then washed with FBS-containing media. Cells were dispersed into single-cell suspensions using a 70 micron nylon mesh (Fisher), washed and resuspended in 1-3 mL of ACK lysis buffer (Quality Biological, Maryland, USA) on ice for 3 min. Non-specific binding was blocked by pretreating cells with rat anti-mouse CD16/32 mAb (clone 2.4G2 BD Biosciences, San Jose, California, USA) for 10 min at room temperature. Cells were stained using predetermined optimised mAb concentration, and events (1 000 000) were collected on a FACSAriaII flow cytometer (BD Biosciences) and were analysed using FlowJo software (Tree Star, Ashland, Oregon, USA).
Mouse osteoclast cultures
Cells unlabelled or labelled with anti-RANK were sorted using FACSAriaII cell sorter (BD Biosciences). Cells were washed and cultured on 5 mm glass coverslips in a 96-well plate at 37 o C with 5% CO 2 for 4 days in the presence of M-CSF (25 ng/mL) and/or RANKL (60 ng/mL). The cells cultured on plastic dishes were stained for TRAP using a commercial kit (387-A, Sigma) according to manufacturer's instructions. F-actin rings were visualised as previously described. 9 Collagen-induced arthritis Female C57BL/6J mice (The Jackson Laboratory, Sacramento, California, USA) were injected with either GFP or IL-17A MC DNA 3 days before getting immunised with bovine type II collagen (CII) (Sigma-Aldrich, St Louis, Missouri, USA) emulsified intradermally with complete Freund's adjuvant (DIFCO, Detroit, MI). 50 μL of 1 mg/mL CII/CFA emulsion was injected on both sides of the tail base. Mice were challenged intradermally 21 days later with 1 mg/mL CII emulsified in incomplete Freund's adjuvant. Mice were observed daily before and after the first signs of swollen paws within the cohort scored and processed for micro-CT imaging (μCT) as previously described. 23 
Transmission electron microscopy
Skin samples taken from dorsal skin were fixed overnight in buffered 2.5% glutaraldehyde and 2% formaldehyde, washed in buffer, dehydrated in an ethanol series and flat embedded in epoxy resin. One-micrometer sections for light microscopy, stained with methylene blue and azure II, were reviewed with selected areas thin sectioned and then stained with uranyl acetate and lead citrate. Transmission electron microscopic imaging was performed with an FEI, Inc. model CM10 equipped with a Gatan Orius camera system.
RNA extraction and real-time quantitative PCR
Total RNA was purified from different stages of osteoclast cultures using the RNeasy Mini Kit (QIAGEN). Gene expression was calculated using the Δ-ΔCt method (using the mean cycle threshold value for ubiquitin and the gene of interest for each sample). The equation 1.8e (Ct ubiquitin-Ct gene of interest) × 10 4 was used to obtain the normalised values.
Statistical analysis
Data were analysed by Student t test and Mann-Whitney nonparametric tests as indicated in the figure legends of each assay. One-way or two-way ANOVA with Bonferroni after test were used where appropriate. p<0.05 was considered to be statistically significant (n=3, unless otherwise indicated).
RESULTS
IL-17A gene transfer in vivo induces two distinct myeloid populations
A recombinant MC construct encoding the IL-17A gene (see online supplementary figure S1) was injected hydrodynamically into the tail vein to establish systemic expression of IL-17A in vivo due to transduction of hepatocytes. 9 22 A GFP MC DNA construct was also injected hydrodynamically as a negative control and could be visualised 24 h after injection using a two-dimensional (2D) fluorescence imager Maestro 2 ( figure 1A,B) . +high populations (figure 1D,E). These data were recorded within 7 days post gene transfer, at a timepoint when other cytokines were not detectably elevated in the serum by a multiplex bead array assay from an extensive cytokine panel To characterise the pathologic potential of systemic IL-17A expression and the contribution of secondary cytokines downstream of IL-17A in synovial inflammation and bone destruction, we examined H&E-stained decalcified limb samples from the IL-17A MC-injected mice at 7 weeks after gene transfer.
There was no evidence of visual paw swelling, nor was histological joint inflammation observed ( figure 2A) . Surprisingly, IL-17A MC-injected mice showed signs of systemic bone erosion by μCT in the absence of overt inflammation (figure 2B), and the increased bone resorption correlated with a significant increase in serum TRAP5b with serum RANKL remaining unchanged ( figure 2C,D) .
To further investigate this observation, we isolated CD11b + cells from bone marrow and spleen of GFP MC or IL-17A MC-injected animals and characterised them by flow cytometry. Our data show that IL-17A gene transfer induced the key osteoclastogenic receptors RANK (mean± SD) (1.5%± 0.1%) and CSF-1R (13%±1.1%) in the bone marrow ( figure 2E ) and spleen (1.0% ± 0.2 and 2.0% ± 0.2, respectively) (figure 2F). Since both these receptors are crucial in the differentiation of monocytes to osteoclasts, 24 next we sought to identify whether the changes in RANK expression in osteoclast precursors affected the rate of osteoclastogenesis in vivo.
Carboxy-terminal collagen cross-links (CTX-I) in serum (a marker of bone resorption) showed a non-significant increased trend in the IL-17A MC over GFP MC, which probed us to investigate the effect of IL-17A on bone destruction further (see online supplementary figure S2a,b). A RANKL expressing MC vector was injected hydrodynamically to establish systemic expression of RANKL in vivo in IL-17A or GFP overexpressing C57BL/6 mice (see online supplementary figure S2c). These experiments showed that mice with double gene transfer of IL-17A and RANKL had significantly elevated TRAP5b, which persisted 11 days ( p=0.0022) and 38 days ( p=0.0166) post-RANKL gene transfer ( figure 2G ).
IL-17A induces osteoclast differentiation in a RANKL-dependent manner in vitro
To validate our in vivo findings, we performed osteoclast assays in vitro by culturing bone marrow macrophages in the presence of M-CSF and RANKL. RANK + -sorted bone marrow macrophages from IL-17A MC-injected mice showed a marked increase in multinucleated TRAP + cells that were capable of F-actin ring formation compared with GFP MC controls ( figure  3A-C) . This also correlated with a marked increase of IL17ra, Csf1r and Nfatc1 mRNA compared with GFP MC controls ( figure 3D ). Finally, flow cytometric analysis revealed an increase of RANK expression on cells extracted from bone marrow after IL-17A MC injection relative to GFP MC controls ( figure 3E ).
IL-17A exacerbates synovial inflammation and bone loss in inflammatory arthritis
Next we sought to investigate the effect of systemic IL-17A in inflammatory arthritis by performing IL-17A gene transfer in a collagen-induced arthritis (CIA) mouse model. Gene transfer of IL-17A exacerbated arthritis disease severity based on paw swelling and initiated arthritis at much earlier timepoints as compared with GFP MC controls ( figure 4A,B) . H&E-stained decalcified limb samples of IL-17A gene transfer mice revealed a hyperplastic and inflamed synovium, which contained a mixed inflammatory infiltrate consisting of mononuclear cells and numerous polymorphonuclear leukocytes. Neovascularisation and proliferation of fibrocellular pannus was also pronounced. In some areas, the pannus had eroded into adjacent cartilage, and occasionally completely obliterated the normal joint architecture as confirmed by μCT ( figure 4C,D) . In addition to using visual paw swelling scores, histology scores confirmed exacerbated histological parameters of arthritis, including pannus formation, reactive synovium, leucocyte infiltration, cartilage proliferation, and bone erosion and destruction (see online supplementary figure S3 ). The prominent bone destruction correlated with a significant increase of Rankl, Trap and Mmp9 mRNA levels in keeping with an osteoclast signature (figure 4E).
Systemic IL-17A induces cutaneous disease
We examined H&E-stained ear and dorsal skin samples from IL-17A MC-injected mice 7 weeks post gene transfer to characterise the potential role of systemic IL-17A in skin inflammation. IL-17A gene transfer resulted in diffuse epidermal hyperplasia (acanthosis) with associated compact hyperkeratotic and parakeratosis of the stratum corneum (figure 5A). The visual skin pathology occurred randomly within a cohort of IL-17A MC-injected mice between 5 days and 8 weeks post-transfer and occurred on the ears, face, behind the neck, dorsal skin and axilla. In contrast, mice treated with control MC had a normal appearing thin epidermis and stratum corneum (figure 5B). The skin observations were in keeping with a greater than 5000-fold increase in keratin 16 (K16) mRNA, a marker of keratinocyte hyperproliferation ( figure  5C ). Dorsal skin excised from IL-17A MC injected mice revealed the formation of a mixed inflammatory infiltrate consisting of polymorphonuclear leukocytes (Munro's microabscesses) in the upper dermis associated around dilated capillaries with noted uniform epidermal hyperplasia ( figure 5D ). The mixed inflammatory infiltrates were absent in the GFP MC controls. These cutaneous observations in the IL-17A gene transfer cohort were correlated with a dramatic (up to 80% of all nucleated blood cells) increase in neutrophils within 24 h of IL-17A gene transfer as detected by haematological analysis (figure 5E). Transmission electron microscopy (TEM) of dorsal skin also revealed the major ultrastructural features of IL-17A-induced epidermal hyperplasia, including hypertrophy and hyperplasia of the spinous layer with spongiosis and retained nuclei and compacted keratin filaments in the keratin layer. A mild uniform intercellular oedema of the epidermis (figure 5F) with retained nuclei in the upper epidermis ( figure 5G ) and compact hyperkeratosis of the stratum corneum (figure 5H) were prominent epidermal changes associated with elevated IL-17A that were absent in control mice.
DISCUSSION
The relevance of IL-23 and IL-17 in PsA is suggested by the elevation of IL-23, IL-17/IL-17R in psoriatic skin and synovial fluid from PsA patients. 8 25 Single-nucleotide polymorphisms in IL23A, IL23R, as well as TRAF3IP2 (Act1), a downstream target of the IL-17 receptor (IL-17R), confer susceptibility to PsA, implying a central role of the IL-23/ IL-17A axis in PsA pathogenesis. 26 27 Since IL-23 regulates the differentiation of IL-17-producing T h 17 cells, it is hard to evaluate the significance of IL-17A in disease pathogenesis independently of IL-23 and other T h 17-related cytokines. 28 To address the direct role of IL-17A in bone and skin pathology associated with PsA, we employed a gene transfer approach to overexpress IL-17A in vivo, thereby dissecting IL-17A from the IL-23/T h 17 biology. IL-17A, consistent with previous reports, induced myelopoiesis and neutrophilia. 29 Serum analysis after 1, 3, 7 days and 7 weeks showed that only IL-17A was detectable within the first 72 h; however, other cytokines were also increased with chronic exposure to IL-17A. Notably, TNF was not significantly elevated even 7 weeks post-IL-17A gene transfer. Granulocyte macrophage activating factor (GM-CSF), a cytokine known to play a role in maintaining myelopoiesis in autoimmune diseases, was elevated 7 weeks post gene transfer, and although it may play a role in perpetuating the myeloid signature it was not associated with the initial myelopoiesis. 30 31 As there was no other cytokine apart from IL-17A directly associated with the expanded myeloid populations, our data clearly show a direct association between IL-17A and myelopoiesis in our model and confirm previous observations. Interestingly, gene transfer of IL-17A induced serum TRAP and bone destruction as observed by μCT in the absence of synovial inflammation. This was not associated with an increase in sRANKL, but was associated with an expansion of an IL-17R IL-17A −/− mice are protected from joint disease in the CIA mouse model due to reduced anti-collagen antibody titre and collagen-specific T cell proliferation; however, the role of IL-17A in initiating inflammatory arthritis remains elusive. 32 To test this, we performed the CIA model in female C57BL/6 mice, which are resistant in this particular experimental model of arthritis in mice overexpressing IL-17A or GFP. 33 IL-17A exacerbated the disease progression compared with GFP controls and showed a strong upregulation of Rankl, Trap and Mmp9 mRNA, correlating with the osteoclast-related gene activation signature. Based on our findings, we propose that IL-17A has at least a dual effect in inflammatory arthritis. First, IL-17A upregulates RANK on pre-osteoclasts, making them hypersensitive to RANKL signal, and second, IL-17A increases serum RANKL in the circulation. Collectively this set of data suggests a role of IL-17A in bone destruction in inflammatory arthritis. Bone and joint destruction in IL-17A gene transfer coincided with skin pathology. Specifically, a diffuse epidermal hyperplasia (acanthosis) with associated compact hyperkeratotic and parakeratosis of the stratum corneum and formation Munro's microabscesses in the upper dermis were consistent with a greater than 5000-fold increase in keratin 16 (K16) mRNA, a marker of keratinocyte hyperproliferation. The skin pathology was absent in the GFP MC controls. These cutaneous observations in the IL-17A gene transfer cohort were correlated with a dramatic (up to 80% of all nucleated blood cells) increase in CD11b 
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high neutrophils commonly occurs in Munro's microabscess, and their depletion reduces epidermal thickening and microabscess formation in flaky skin mice. [34] [35] [36] It is possible that IL-17A, in addition to inducing the expansion of IL-17R 
